摘要
背景:从遗传学收敛的证据,症状和精神药理学的暗示有精神分裂症的内在联系(SCZ)、双相情感障碍(BPD)和抑郁症(MDD),例如,任何两个甚至三个这些疾病可能在一些家庭并存。 目的:筛选出易感基因位于6号染色体上的全面SCZ,在中国在一个相对同质的群体BPD和MDD。 方法:总共有56.400个单核苷酸多态性(SNPs)6号染色体上的基因的Affymetrix人的全基因组SNP阵列6 119 SCZ,253桶(类型I)、177例抑郁症患者和1000名对照。 结果:相关的SNP位点在染色体6综合显示和突出的易感基因的鉴定包括JARID2(智人十文字,在丰富的互动域2)是胚胎发育的神经管融合过程中的重要作用。不料,侧翼基因的所有相关的单核苷酸多态性在986 SCZ患者扩大队列复制。 结论:考虑到所有的证据,我们的研究结果表明,双相情感障碍和重度抑郁症是精神分裂症的亚型。此外,JARID2是这个群体中一个重要的精神病基因。
关键词: 精神分裂症的亚型,双相情感障碍,抑郁症,JARID2,基因。
Current Molecular Medicine
Title:A Novel Relationship for Schizophrenia, Bipolar and Major Depressive Disorder Part 6: A Hint from Chromosome 6 High Density Association Screen
Volume: 16 Issue: 9
Author(s): X. Chen, F. Long, B. Cai, X.H. Chen, G. Chen
Affiliation:
关键词: 精神分裂症的亚型,双相情感障碍,抑郁症,JARID2,基因。
摘要: Background: Convergent evidence from genetics, symptomatology and psychopharmacology imply that there are intrinsic connections between schizophrenia (SCZ), bipolar disorder (BPD) and major depressive disorder (MDD), for example, any two or even three of these disorders could co-exist in some families.
Objective: To screen out the susceptibility genes on chromosome 6 comprehensively for SCZ, BPD and MDD in a relative homogenous population in China. Method: A total of 56.400 single nucleotide polymorphism (SNPs) on chromosome 6 were genotyped by Affymetrix Genome-Wide Human SNP array 6.0 on 119 SCZ, 253 BPD (type- I), 177 MDD patients and 1000 controls. Results: Associated SNP loci on chromosome 6 were comprehensively revealed and outstanding susceptibility genes were identified including JARID2 (Homo sapiens jumonji, AT rich interactive domain 2) which plays an essential role in embryonic development and neural tube fusion process. Unexpectedly, flanking genes for all associated SNPs were replicated in an enlarged cohort of 986 SCZ patients. Conclusion: Considering all evidence, our results imply that both of bipolar disorder and major depressive disorder are subtypes of schizophrenia. Furthermore, JARID2 is an important psychosis gene in this population.Export Options
About this article
Cite this article as:
X. Chen, F. Long, B. Cai, X.H. Chen, G. Chen , A Novel Relationship for Schizophrenia, Bipolar and Major Depressive Disorder Part 6: A Hint from Chromosome 6 High Density Association Screen, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128115135
DOI https://dx.doi.org/10.2174/1566524016666161128115135 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Store-Dependent Ca2+ Entry in Endothelial Progenitor Cells As a Perspective Tool to Enhance Cell-Based Therapy and Adverse Tumour Vascularization
Current Medicinal Chemistry Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Current Gene Therapy The p53-Mdm2 Pathway: Targets for the Development of New Anticancer Therapeutics
Mini-Reviews in Medicinal Chemistry A Comprehensive Review on Pharmacology and Toxicology of Bioactive Compounds of <i>Lagerstroemia Speciosa(L.</i>) Pers.
Current Traditional Medicine Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
Recent Patents on Anti-Cancer Drug Discovery CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds
Current Neuropharmacology Regulation of Gene Expression by Progesterone in Cancer Cells: Effects on Cyclin D1, EGFR and VEGF
Mini-Reviews in Medicinal Chemistry Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies
Anti-Cancer Agents in Medicinal Chemistry A Transcriptomics Study to Elucidate the Toxicological Mechanism of Methylmercury Chloride in a Human Stem Cell Based In Vitro Test
Current Medicinal Chemistry Gene Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Role of Retinoids, Rexinoids and Thyroid Hormone in the Expression of Cytochrome P450 Enzymes
Current Drug Metabolism rDNA Mediated Bioconjugates: Fusion Proteins and their Intended Use in Medicine
Current Topics in Medicinal Chemistry Stem Cell Function, Self-Renewal, Heterogeneity, and Regenerative Potential in Skeletal Muscle Stem Cells
Recent Patents on Regenerative Medicine Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets Targeted Pathways in Breast Cancer: Molecular and Protein Markers Guiding Therapeutic Decisions
Current Molecular Pharmacology Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
Anti-Cancer Agents in Medicinal Chemistry Activation of Myosin Phosphatase by Epigallocatechin-Gallate Sensitizes THP-1 Leukemic Cells to Daunorubicin
Anti-Cancer Agents in Medicinal Chemistry Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery